Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1245 | 2764 | 27.3 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
85 | 2 | ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN | 27105 |
1245 | 1 | CAS 89396 94 1//TA 6366//IMIDAPRIL | 2764 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CAS 89396 94 1 | authKW | 99411 | 0% | 100% | 9 |
2 | TA 6366 | authKW | 99411 | 0% | 100% | 9 |
3 | IMIDAPRIL | authKW | 84798 | 1% | 32% | 24 |
4 | QUINAPRIL | authKW | 53741 | 1% | 17% | 28 |
5 | FOSINOPRIL | authKW | 47798 | 1% | 18% | 24 |
6 | TRANDOLAPRIL | authKW | 47089 | 1% | 18% | 24 |
7 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | journal | 46319 | 8% | 2% | 215 |
8 | CILAZAPRIL | authKW | 45677 | 1% | 17% | 25 |
9 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | authKW | 42276 | 4% | 3% | 111 |
10 | BENAZEPRIL | authKW | 41999 | 1% | 17% | 23 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 22835 | 53% | 0% | 1460 |
2 | Cardiac & Cardiovascular System | 6884 | 20% | 0% | 564 |
3 | Peripheral Vascular Diseases | 4875 | 13% | 0% | 356 |
4 | Medicine, General & Internal | 1442 | 12% | 0% | 331 |
5 | Medicine, Research & Experimental | 830 | 8% | 0% | 209 |
6 | Chemistry, Medicinal | 762 | 6% | 0% | 156 |
7 | Physiology | 422 | 5% | 0% | 145 |
8 | Urology & Nephrology | 131 | 3% | 0% | 77 |
9 | Toxicology | 130 | 3% | 0% | 79 |
10 | Geriatrics & Gerontology | 1 | 0% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SAFETY YODOGAWA KU | 24851 | 0% | 75% | 3 |
2 | 141149 STAINES RD | 11046 | 0% | 100% | 1 |
3 | BIOMED INFORMAT SAKYO KU | 11046 | 0% | 100% | 1 |
4 | CARDIOVASC SALVATORE MAUGERI | 11046 | 0% | 100% | 1 |
5 | CENT CHEM YODOGAWA KU | 11046 | 0% | 100% | 1 |
6 | CHAIR GERIATR PATHOL | 11046 | 0% | 100% | 1 |
7 | CLIN PHARM PHARMACOTHERP Y | 11046 | 0% | 100% | 1 |
8 | EUSKAL ERICO UNIBERSITATAE | 11046 | 0% | 100% | 1 |
9 | HENNEPIN CTY MED MED NEPHROL | 11046 | 0% | 100% | 1 |
10 | HIV COORDINATING | 11046 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 46319 | 8% | 2% | 215 |
2 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 33990 | 2% | 5% | 65 |
3 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 25056 | 5% | 2% | 136 |
4 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 21589 | 4% | 2% | 97 |
5 | JOURNAL OF HYPERTENSION | 11081 | 4% | 1% | 99 |
6 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 7519 | 2% | 1% | 55 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 7339 | 2% | 1% | 69 |
8 | JOURNAL OF HUMAN HYPERTENSION | 7168 | 2% | 1% | 49 |
9 | JOURNAL OF CLINICAL PHARMACOLOGY | 6294 | 2% | 1% | 56 |
10 | DRUGS | 5453 | 2% | 1% | 53 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAS 89396 94 1 | 99411 | 0% | 100% | 9 | Search CAS+89396+94+1 | Search CAS+89396+94+1 |
2 | TA 6366 | 99411 | 0% | 100% | 9 | Search TA+6366 | Search TA+6366 |
3 | IMIDAPRIL | 84798 | 1% | 32% | 24 | Search IMIDAPRIL | Search IMIDAPRIL |
4 | QUINAPRIL | 53741 | 1% | 17% | 28 | Search QUINAPRIL | Search QUINAPRIL |
5 | FOSINOPRIL | 47798 | 1% | 18% | 24 | Search FOSINOPRIL | Search FOSINOPRIL |
6 | TRANDOLAPRIL | 47089 | 1% | 18% | 24 | Search TRANDOLAPRIL | Search TRANDOLAPRIL |
7 | CILAZAPRIL | 45677 | 1% | 17% | 25 | Search CILAZAPRIL | Search CILAZAPRIL |
8 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | 42276 | 4% | 3% | 111 | Search ANGIOTENSIN+CONVERTING+ENZYME+INHIBITORS | Search ANGIOTENSIN+CONVERTING+ENZYME+INHIBITORS |
9 | BENAZEPRIL | 41999 | 1% | 17% | 23 | Search BENAZEPRIL | Search BENAZEPRIL |
10 | RAMIPRIL | 41117 | 2% | 9% | 42 | Search RAMIPRIL | Search RAMIPRIL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEBLANC, JM , DASTA, JF , PRUCHNICKI, MG , SCHENTAG, JJ , (2006) IMPACT OF DISEASE STATES ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 46. ISSUE 9. P. 968 -980 | 65 | 92% | 5 |
2 | TODD, PA , HEEL, RC , (1986) ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE.DRUGS. VOL. 31. ISSUE 3. P. 198-248 | 115 | 74% | 281 |
3 | KELLY, JG , OMALLEY, K , (1990) CLINICAL PHARMACOKINETICS OF THE NEWER ACE INHIBITORS - A REVIEW.CLINICAL PHARMACOKINETICS. VOL. 19. ISSUE 3. P. 177-196 | 80 | 89% | 80 |
4 | SALVETTI, A , (1990) NEWER ACE INHIBITORS - A LOOK AT THE FUTURE.DRUGS. VOL. 40. ISSUE 6. P. 800-828 | 85 | 77% | 75 |
5 | BROGDEN, RN , TODD, PA , SORKIN, EM , (1988) CAPTOPRIL - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE HEART-FAILURE.DRUGS. VOL. 36. ISSUE 5. P. 540-600 | 158 | 44% | 84 |
6 | HOYER, J , SCHULTE, KL , LENZ, T , (1993) CLINICAL PHARMACOKINETICS OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS IN RENAL-FAILURE.CLINICAL PHARMACOKINETICS. VOL. 24. ISSUE 3. P. 230-254 | 74 | 77% | 48 |
7 | TODD, PA , BENFIELD, P , (1990) RAMIPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN CARDIOVASCULAR DISORDERS.DRUGS. VOL. 39. ISSUE 1. P. 110-135 | 69 | 78% | 74 |
8 | MCAREAVEY, D , ROBERTSON, JIS , (1990) ANGIOTENSIN CONVERTING ENZYME-INHIBITORS AND MODERATE HYPERTENSION.DRUGS. VOL. 40. ISSUE 3. P. 326-345 | 78 | 62% | 56 |
9 | SICA, DA , (1992) KINETICS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN RENAL-FAILURE.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 20. ISSUE . P. S13-S20 | 50 | 88% | 16 |
10 | ANTONACCIO, MJ , (1982) ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 22. ISSUE . P. 57-87 | 98 | 69% | 114 |
Classes with closest relation at Level 1 |